BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26415081)

  • 1. IL-21-Expressing Mesenchymal Stem Cells Prevent Lethal B-Cell Lymphoma Through Efficient Delivery of IL-21, Which Redirects the Immune System to Target the Tumor.
    Kim N; Nam YS; Im KI; Lim JY; Lee ES; Jeon YW; Cho SG
    Stem Cells Dev; 2015 Dec; 24(23):2808-21. PubMed ID: 26415081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma.
    Jeong KY; Lee EJ; Kim SJ; Yang SH; Sung YC; Seong J
    Int J Cancer; 2015 Aug; 137(3):721-30. PubMed ID: 25639194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma.
    Gao P; Ding Q; Wu Z; Jiang H; Fang Z
    Cancer Lett; 2010 Apr; 290(2):157-66. PubMed ID: 19786319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
    Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
    Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.
    Guo H; Zhao N; Gao H; He X
    Scand J Immunol; 2017 Nov; 86(5):389-395. PubMed ID: 28888053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice.
    Hu W; Wang J; He X; Zhang H; Yu F; Jiang L; Chen D; Chen J; Dou J
    Biotechnol Appl Biochem; 2011; 58(6):397-404. PubMed ID: 22172102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity.
    Seo SH; Kim KS; Park SH; Suh YS; Kim SJ; Jeun SS; Sung YC
    Gene Ther; 2011 May; 18(5):488-95. PubMed ID: 21228885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model.
    Elzaouk L; Moelling K; Pavlovic J
    Exp Dermatol; 2006 Nov; 15(11):865-74. PubMed ID: 17002683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells.
    Grille S; Brugnini A; Nese M; Corley E; Falkenberg FW; Lens D; Chabalgoity JA
    Cancer Immunol Immunother; 2010 Apr; 59(4):519-27. PubMed ID: 19768458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect.
    Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N
    Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-2 expression above a threshold elicits anti-tumor immunity as effective as interleukin-12 and prolongs survival in murine B-cell lymphoma.
    Pizzoferrato E
    Int J Cancer; 2004 May; 110(1):61-9. PubMed ID: 15054869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer.
    Bitsika V; Roubelakis MG; Zagoura D; Trohatou O; Makridakis M; Pappa KI; Marini FC; Vlahou A; Anagnou NP
    Stem Cells Dev; 2012 May; 21(7):1097-111. PubMed ID: 21988169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model.
    Sartoris S; Mazzocco M; Tinelli M; Martini M; Mosna F; Lisi V; Indraccolo S; Moserle L; Cestari T; Riviera AP; Bifari F; Tridente G; Pizzolo G; Krampera M
    Stem Cells Dev; 2011 Apr; 20(4):709-19. PubMed ID: 20695752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.
    Ryu CH; Park SH; Park SA; Kim SM; Lim JY; Jeong CH; Yoon WS; Oh WI; Sung YC; Jeun SS
    Hum Gene Ther; 2011 Jun; 22(6):733-43. PubMed ID: 21261460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Inhibitory Effect of Mesenchymal Stem Cells with rAd-NK4 on Liver Cancer.
    Cai C; Hou L; Zhang J; Zhao D; Wang Z; Hu H; He J; Guan W; Ma Y
    Appl Biochem Biotechnol; 2017 Sep; 183(1):444-459. PubMed ID: 28353041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.